Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

Completed · Phase 2

Conditions studied: Coronary Disease, Coronary Artery Disease, Coronary Restenosis

In brief

The purpose of this study is to demonstrate the safety and efficacy of the ZoMaxx drug-eluting stent in patients with blockage of native coronary arteries. The study is designed to demonstrate non-inferiority to the TAXUS Express2 Paclitaxel-Eluting Stent that has proven superior to bare metal stents and is a recognized standard of care.

Key facts

Study ID
NCT00140101
Run by
Abbott Medical Devices
People needed
1099
Starts
2005-05-01
Expected to finish
2012-01-01
Last updated by the study team
2012-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.